Search for: "Teva Pharmaceuticals"
Results 1021 - 1040
of 1,430
Sort by Relevance
|
Sort by Date
27 Sep 2010, 4:55 am
This is due to competition by a generic of Yaz, manufactured by Teva Pharmaceuticals. [read post]
26 Sep 2010, 10:08 pm
Teva Pharmaceuticals USA Inc. et al (Docket Report) District Court N D Illinois: Draft opinion letter sinks induced infringement claim: Goss International Americas, Inc. v. [read post]
24 Sep 2010, 1:22 pm
Patent No. 7,126,008 owned by Teva Pharmaceutical Industries Ltd. and entitled CARVEDILOL. [read post]
24 Sep 2010, 1:15 pm
Teva Pharmaceuticals USA, Inc., 566 F.3d 989 (Fed. [read post]
23 Sep 2010, 12:02 pm
Teva Pharmaceuticals USA Inc. et al., 1-08-cv-00464 (DED September 21, 2010 Memorandum) (Bartle, J.) [read post]
21 Sep 2010, 7:47 pm
(FDA Law Blog) US: FDA set to announce public hearing on BPCI Act implementation (FDA Law Blog) US: Precision Biosciences granted stay pending reexam of Cellectis’ patents (Patent Docs) US: Celsis granted preliminary injunction against CellzDirect in LiverPool hepatocyte treatment infringement suit (Patent Docs) US: Yeda Research and Development files suit against Abbott in District of Columbia requesting review of BPAI decision (Patent Docs) Products Angiomax (Bivalirudin) – US: The… [read post]
16 Sep 2010, 9:54 pm
By James DeGiulio -- Sandoz, Momenta Fail to Invalidate Teva Patents in Copaxone Suit Teva Pharmaceutical Industries received a favorable ruling in its Copaxone patent infringement suit against Sandoz and Momenta Pharmaceuticals after their motion for summary judgment seeking to invalidate Teva's patents over the drug was denied. [read post]
15 Sep 2010, 2:40 am
KG v Apotex Pty Ltd (No 2) (Patentology) MoviPrep – US: Salix and Norgine settle with Novel in patent dispute over MoviPrep (Patent Docs) Nexavar (Sorafenib) – India: Nexavar patent infringement suit before Delhi HC goes directly to trial: Bayer v Cipla (Spicy IP) Simcor (Niacin/Simvastatin) – US: Abbott files patent infringement suit against Teva following Para IV challenge (Patent Docs) Vancocin (Vancomycin) – US: ViroPharma sues FDA over generic Vancocin; alleges… [read post]
12 Sep 2010, 9:55 pm
Teva Pharmaceutical Industries Ltd. et al. 1:10-cv-00766; filed September 8, 2010 in the District Court of Delaware • Plaintiffs: Abbott Laboratories; Abbott Respiratory LLC • Defendants: Teva Pharmaceutical Industries Ltd.; Teva Pharamceuticals USA, Inc. [read post]
9 Sep 2010, 4:01 pm
"Reuters had written:On April 29, a three-judge panel in New York upheld a lower court's ruling dismissing objections to Bayer AG paying Teva Pharmaceutical Industries Inc's Barr Laboratories to prevent it from bringing to market a version of the anthrax drug Cipro.But the panel invited further review by the full nine-judge panel of the U.S. [read post]
8 Sep 2010, 9:24 am
Teva made the drug and Baxter distributed it according to the lawsuit. [read post]
7 Sep 2010, 6:10 pm
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin Amgen,… [read post]
6 Sep 2010, 9:48 pm
Teva Pharmaceuticals USA, Inc. [read post]
4 Sep 2010, 8:29 pm
Teva Pharmaceuticals USA (CAFC 2010-1005, 1033) precedential Teva argued the Bone Loss Patents and Low Dose Patent were obvious. [read post]
3 Sep 2010, 12:35 pm
Teva Pharmaceuticals, 2010 U.S. [read post]
2 Sep 2010, 10:51 am
Teva Pharmaceuticals USA, Inc., 566 F.3d 989 (Fed. [read post]
2 Sep 2010, 10:21 am
On September 1st, APP Pharmaceuticals, LLC, which previously submitted an amicus brief in the case (as did Teva Pharmaceuticals - here), filed a Notice of Appeal to the U.S. [read post]
1 Sep 2010, 6:49 am
(Apotex subsequently submitted an Emergency Petition for Stay of Action to FDA asking the Agency to strip Teva of its final ANDA aproval – once again based on the mistaken belief that Teva is not eligible for 180-day exclusivity. [read post]
31 Aug 2010, 10:01 pm
(Spicy IP) India: DIPP discussion paper on compulsory licensing in the Indian Pharmaceutical sector: An ‘acquired’ afterthought? [read post]
24 Aug 2010, 4:13 am
Legal News Tags, attorney yasmin, attorney yaz, birth control yasmin, birth control yaz, blood clots, Dallas yasmin attorney, Dallas yasmin law firm, Dallas yaz attorney, Southlake yaz attorney, Keller yaz attorney, Grapevine yaz attorney, Austin yaz attorney, Dallas yaz mdl, Fort Worth yaz mdl attorney, Fort Worth yaz attorney, San Antonio yaz attorney, El Paso yaz attorney, Texas yaz attorney, Dallas yaz law firm, deep vein thrombosis, drospirenone, gallbladder damage, lawyer yasmin, lawyer yaz,… [read post]
